Agoracom Logo
sign in
sign in
register
Rules
Sign in with Facebook
Sign in with Linkedin
Forgot your username or password? Recover it here
Not a member yet? Register
Didn't receive confirmation instructions? Resend
  • INVESTORS
    • My Home
    • Small Cap Marketplace
    • Broadcast Center
    • Request New Hub
    • Quick Tips
    • Ratings & Ranks
  • PUBLIC COMPANIES
    • Investor Relations
    • Success Stories
    • Clients
    • Testimonials
    • Contact
  • Conferences
  • About us
wellsbro2
wellsbro2
Follow
Rank: Mail Room [?]
Points: 184 [?]
Votes: 5 Score: 4.6 [?]
Your Vote:
Please Log In to Vote
profile Post History
wellsbro2's Recent Posts
Title Rating Company Posted on
Re: MannKind Corporation to Present at The 24th Annual Piper Jaffray Healthcare Conf Mannkind Nov 27, 2012 01:52PM
Re: Al won't lend more Re: How about a few guesses as to the terms of the offering? 1 Mannkind Oct 19, 2012 02:01AM
Re: Share price drop scenario 3 Mannkind Oct 10, 2012 11:30PM
Perfect Storm 1 Mannkind Sep 09, 2012 12:50AM
Re: Silentbobsilent sorts out the Exubera Study 3 Mannkind Sep 07, 2012 12:18AM
Re: Has PFE announced results of Exubera patients follow-up trial? Mannkind Aug 27, 2012 11:12PM
Re: Shkreli Letter - chmith27 Med Input 1 Mannkind Aug 19, 2012 09:59PM
Re: I Agree 1 Mannkind Aug 17, 2012 04:07PM
Re: I Agree Mannkind Aug 17, 2012 01:51PM
Stellar Micro Mannkind Jul 24, 2012 05:13PM
Short interest 1 Mannkind Jul 24, 2012 05:11PM
Re: Short Interest Mannkind Jul 11, 2012 10:44PM
Short Interest Mannkind Jul 11, 2012 06:10PM
Re: It's from an old article from 2009 but... Mannkind Jul 06, 2012 08:28PM
Re: Warrant help. Checking my math! Mannkind Jun 23, 2012 04:09PM
agoracom
Follow us on: twitter facebook youtube
  • Privacy Policy
  • Terms and Conditions
  • Contact
  • Help

Log in to Agoracom

Sign in with Facebook
Sign in with Linkedin
Forgot your username or password? Recover it here
Not a member yet? Register
Didn't receive confirmation instructions? Resend
Contact Us
Speak with an Agoracom representative today.